Home Research COVID-19 Services Publications People Teaching Job Opening News Forum Lab Only
Online Services

I-TASSER I-TASSER-MTD C-I-TASSER CR-I-TASSER QUARK C-QUARK LOMETS MUSTER CEthreader SEGMER DeepFold DeepFoldRNA FoldDesign COFACTOR COACH MetaGO TripletGO IonCom FG-MD ModRefiner REMO DEMO DEMO-EM SPRING COTH Threpp PEPPI BSpred ANGLOR EDock BSP-SLIM SAXSTER FUpred ThreaDom ThreaDomEx EvoDesign BindProf BindProfX SSIPe GPCR-I-TASSER MAGELLAN ResQ STRUM DAMpred

TM-score TM-align US-align MM-align RNA-align NW-align LS-align EDTSurf MVP MVP-Fit SPICKER HAAD PSSpred 3DRobot MR-REX I-TASSER-MR SVMSEQ NeBcon ResPRE TripletRes DeepPotential WDL-RF ATPbind DockRMSD DeepMSA FASPR EM-Refiner GPU-I-TASSER

BioLiP E. coli GLASS GPCR-HGmod GPCR-RD GPCR-EXP Tara-3D TM-fold DECOYS POTENTIAL RW/RWplus EvoEF HPSF THE-DB ADDRESS Alpaca-Antibody CASP7 CASP8 CASP9 CASP10 CASP11 CASP12 CASP13 CASP14

You can:

GPCR

NameP2Y purinoceptor 6
SpeciesHomo sapiens (Human)
GeneP2RY6
Synonympyrimidinergic receptor P2Y
P2Y6 receptor
P2Y6
P2Y purinoceptor 6
P2Y ATP receptor 6
[ Show all ]
DiseaseN/A
Length328
Amino acid sequenceMEWDNGTGQALGLPPTTCVYRENFKQLLLPPVYSAVLAAGLPLNICVITQICTSRRALTRTAVYTLNLALADLLYACSLPLLIYNYAQGDHWPFGDFACRLVRFLFYANLHGSILFLTCISFQRYLGICHPLAPWHKRGGRRAAWLVCVAVWLAVTTQCLPTAIFAATGIQRNRTVCYDLSPPALATHYMPYGMALTVIGFLLPFAALLACYCLLACRLCRQDGPAEPVAQERRGKAARMAVVVAAAFAISFLPFHITKTAYLAVRSTPGVPCTVLEAFAAAYKGTRPFASANSVLDPILFYFTQKKFRRRPHELLQKLTAKWQRQGR
UniProtQ15077
Protein Data BankN/A
GPCR-HGmod modelQ15077
3D structure modelThis predicted structure model is from GPCR-EXP Q15077.
BioLiPN/A
Therapeutic Target DatabaseN/A
ChEMBLCHEMBL4714
IUPHAR326
DrugBankN/A

Ligand

NameCHEMBL505403
Molecular formulaC19H27N7O21P4
IUPAC name[[(2R,3S,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl] hydrogen phosphate
Molecular weight813.348
Hydrogen bond acceptor23
Hydrogen bond donor10
XlogP-8.6
SynonymsBDBM50270555
{[(2R,3S,5R)-5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}({[({[({[(2R,3S,4R,5R)-5-(2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphory
Inchi KeyFZOKIFDNPVZUQG-DBBURVGMSA-N
Inchi IDInChI=1S/C19H27N7O21P4/c20-18-23-15-12(16(31)24-18)21-6-26(15)11-3-7(27)8(43-11)4-41-48(33,34)45-50(37,38)47-51(39,40)46-49(35,36)42-5-9-13(29)14(30)17(44-9)25-2-1-10(28)22-19(25)32/h1-2,6-9,11,13-14,17,27,29-30H,3-5H2,(H,33,34)(H,35,36)(H,37,38)(H,39,40)(H,22,28,32)(H3,20,23,24,31)/t7-,8+,9+,11+,13+,14+,17+/m0/s1
PubChem CID135528590
ChEMBLCHEMBL505403
IUPHARN/A
BindingDB50270555
DrugBankN/A

Structure

SDF download

2D structure
Lipinski's druglikenessThis ligand has more than 5 hydrogen bond donor.
This ligand has more than 10 hydrogen bond acceptor.
This ligand is heavier than 500 daltons.

Experimental Data

ParameterValueReferenceDatabase source
EC501030.0 nMPMID18514530BindingDB,ChEMBL

zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417